🔎 Trials Near Me

Gara Jalqabaatti › Limfomaa T-Selii › Massachusetts › Boston

Qorannoo klinikaalii Limfomaa T-Selii Boston, MA keessatti

Qorannoo 9 Limfomaa T-Selii f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04803201

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06561048

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05010005

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06854653

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Namoota walitti qabaa jiraSadarkaa 1/2
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04104776

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT05313243

A Registry for People With T-cell Lymphoma

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massachusetts General Hospital (Data Collection Only), Boston
  • Dana Farber Cancer Institute (Data Collection Only), Boston
Umuriin hundi · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT05978141

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Massachusetts General Hospital, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Onk-2025 · NCT06534060

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Cancer Institute, Boston
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Qorannoo Limfomaa T-Selii magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.